A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2006
11/08/2006	CN1857709A Osteopathy treating Chinese medicine
11/08/2006	CN1857702A Detoxicated girald daphne and its externally applied transdermal absorption preparation and preparing process
11/08/2006	CN1857695A Externally applied health care liquid and its preparing method
11/08/2006	CN1857685A Medicine ointment for treating swelling and pain in waist and knees
11/08/2006	CN1857680A Chinese medicine ointment for treating bone disease and its preparing method
11/08/2006	CN1857679A Externally applied Chinese medicine liquid and its preparing method
11/08/2006	CN1857669A Bone fracture treating medicine and its preparing method
11/08/2006	CN1857665A Guli medicine preparation and its preparing process
11/08/2006	CN1857649A Externally applied Chinese medicine wine for eliminating damp and activating Qi
11/08/2006	CN1857636A Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny
11/08/2006	CN1857632A Osteoporosis treating compound Chinese preparation and its preparing process
11/08/2006	CN1857628A Quick fracture setting powder and its production process
11/08/2006	CN1857592A Quality control method for trauma treating Diedahongyao preparation
11/08/2006	CN1857589A Method of measuring icariin and epimedin c content in Xianlinggubao preparation
11/08/2006	CN1857588A Quality control method for Xianlinggubao preparation
11/08/2006	CN1857586A Osteoporsis treating Chinese medicine preparation and its preparing process
11/08/2006	CN1857582A Medicine for preventing and treating bone diseases, cardiac and cerebral vascular diseases, etc.
11/08/2006	CN1857577A Chinese medicine preparation for treating old wound
11/08/2006	CN1857567A Preparing method of coated Tongshu tablet
11/08/2006	CN1857564A Bock greenbrier rhizome liquid capsule and its preparing method
11/08/2006	CN1857561A Osteoporosis treating medicine and its preparing method
11/08/2006	CN1857548A Compound Chinese medicine preparation for invigorating kidney, promoting blood circulation, warming meridian and relieving pain and its preparing process
11/08/2006	CN1857546A Chinese medicine preparation for treating femoral head necrosis
11/08/2006	CN1857544A Chinese medicine preparation for treating hyperosteogeny
11/08/2006	CN1857542A Obstruction-eliminating Qubikang ointment and its preparing method
11/08/2006	CN1857541A Plaster for treating rheumatism and osteoarthrosis
11/08/2006	CN1857540A Oral medicine liquid for treating rheumatic diseases and its preparing method
11/08/2006	CN1857539A Preparing method of plaster for rheumatic arthritis
11/08/2006	CN1857532A Medicated pillow for treating cervical spondylosis
11/08/2006	CN1857528A Damp dispelling and pain relieving externally applied medicine and its preparing method
11/08/2006	CN1857511A Medicinal wine for treating pain in waist and legs, scapulohumeral periarthritis and sciatica
11/08/2006	CN1857483A Effective component of goldhair hedyotis herb and production process of its medicine composition
11/08/2006	CN1857465A Fumigant for treating rheumatic arthritis and its preparing method
11/08/2006	CN1857452A Plaster for treating arthrosis
11/08/2006	CN1857451A Medicated pillow for treating cervical spondylosis
11/08/2006	CN1857413A Medicine for treating gout
11/08/2006	CN1857409A Medicine for treating rheumatic disease, rheumatoid disease and other diseases and its preparing method
11/08/2006	CN1857405A Medicine granule and its preparing method
11/08/2006	CN1857385A Medicine composition for treating cervical spondylosis and its preparing method
11/08/2006	CN1857383A Chinese medicine oral liquid for obstruction-eliminating
11/08/2006	CN1857348A Water soluble Chinese angelica extract and its injection and their preparing process
11/08/2006	CN1857314A Method for treating and eliminating hyperosteogeny with extract of duck saliva and gastric juice
11/08/2006	CN1283798C Polypeptides and polynucleotides from coagulase-negative staphylocoui
11/08/2006	CN1283662C Antagonistic anti-hFAS ligand human antibodies and fragments thereof
11/08/2006	CN1283656C C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
11/08/2006	CN1283311C Medicinal liquor for treating wind damp and traumatic injury pain
11/08/2006	CN1283302C Medicament for treating rheumatoid arthritis and artjritis pauperum
11/08/2006	CN1283291C Compound preparation for bone fracture and its preparation method
11/08/2006	CN1283283C Tendon-extending bone-penetrating spray of and its preparing method
11/08/2006	CN1283254C Use of 23-hydroxy betulic acid in preparing administrative and/or preventive drugs for inhibiting blood vessel formation
11/08/2006	CN1283250C Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof
11/08/2006	CN1283247C Ipriflavone dispersed tablet and its preparation method
11/07/2006	US7132546 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
11/07/2006	US7132506 Peptide having osteogenetic activity and osteogenetic accelerator containing the same
11/07/2006	US7132457 Adamantane derivatives
11/07/2006	US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/07/2006	US7132438 Benzimidazole derivatives
11/07/2006	US7132436 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
11/07/2006	US7132434 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders
11/07/2006	US7132427 Quinazolines and uses thereof
11/07/2006	US7132424 Monocyclic derivatives as matrix metalloproteinase inhibitors
11/07/2006	US7132418 For therapy and prophylaxis of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis, psoriasis
11/07/2006	US7132417 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
11/07/2006	US7132408 Composition and method for inhibiting platelet aggregation
11/07/2006	US7132397 Bone morphogenetic protein antagonist based on the mature protein
11/07/2006	US7132264 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis
11/07/2006	US7132261 Nuclear localization peptides for estrogens; antitumor agents; anticarcinogenic agents; hormone replacement therapy; bradycardial agents
11/07/2006	US7132118 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
11/07/2006	US7132098 Administering a glycosidase that degrades chondroitin sulfate or hyaluronic acid to an intervertebral disk having a nucleus pulposus and an annulus fibrosus, adminstering a growth factor within 24 hours to stimulate formation of a matrix
11/07/2006	CA2416879C Methods of treating cancer and the pain associated therewith using endothelin antagonists
11/07/2006	CA2274093C Substituted pyrimidinone and pyridinone compounds and their use
11/02/2006	WO2006116401A1 C-5 substituted quinazolinone derivatives as selective estrogen receptor beta modulators
11/02/2006	WO2006115193A1 Remedy for xanthoma
11/02/2006	WO2006115188A1 Heterocyclic compound
11/02/2006	WO2006115187A1 Pharmaceutical for prevention or treatment of bone metabolic disease
11/02/2006	WO2006115137A1 2-aminobenzimidazole derivative and use of the same for medical purposes
11/02/2006	WO2006115130A1 Calcium bis[(2s)-3-[3-[(2s)-3-(4-chloro-2-cyanophenoxy)-2- fluoropropoxy]phenyl]-2-isopropoxypropionate] and intermediate thereof
11/02/2006	WO2006115057A1 Artificial cerebrospinal fluid
11/02/2006	WO2006114702A2 Pharmaceutical compositions and methods comprising a combination of a selective estrogen receptor modulator and an aromatase inhibitor
11/02/2006	WO2006087077A3 Hsp90-inhibiting triazole derivatives
11/02/2006	WO2005107748A3 Method of tonic treatment with oxyphenbutazone derivatives
11/02/2006	WO2003072715A3 Gasp1: a follistatin domain containing protein
11/02/2006	US20060248601 Modification of organelle metabolism by unc-51-like kinases roma1 or 2tm proteins
11/02/2006	US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006	US20060247313 administering to a osteoporosis patient an effective amount of a amino acid formulation containing 10 to 40 parts by weight of L-arginine or L-glutamine; 5 to 20 parts of L-valine; 8 to 30 parts of L-isoleucine; and10 to 35 parts of L-leucine; regeneration of tendon and ligamet; antiaging of skin
11/02/2006	US20060247290 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/02/2006	US20060247280 Non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis; 3-Benzyl-5-(benzylthio)-1,2,4-triazole
11/02/2006	US20060247269 Thienopyridone derivatives as kinase inhibitors
11/02/2006	US20060247261 Pyrimidine compounds
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060247226 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
11/02/2006	US20060247223 Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications
11/02/2006	US20060247214 Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
11/02/2006	US20060247179 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
11/02/2006	US20060246110 Sustained release pharmaceutical composition
11/02/2006	US20060246085 Methods for manipulating satiety
11/02/2006	US20060246066 Cleavable reagents for specific delivery to disease sites
11/02/2006	US20060246064 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab
11/02/2006	US20060246042 Cells, culture methods, and their use in autologous transplantation therapy
11/02/2006	US20060246031 Use of cxcl6 chemokine in the prevention or repair cartilage defects

1 ... 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 ... 820